| Assay ID | Title | Year | Journal | Article |
|---|
| AID1347097 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347082 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID1347089 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1296008 | Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening | 2020 | SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
| Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening. |
| AID1347090 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347100 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347099 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347093 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347407 | qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Pharmaceutical Collection | 2020 | ACS chemical biology, 07-17, Volume: 15, Issue:7
| High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle. |
| AID1347424 | RapidFire Mass Spectrometry qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1) | 2019 | The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
| Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens. |
| AID1347106 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347096 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347108 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347095 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
| AID1508630 | Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay | 2021 | Cell reports, 04-27, Volume: 35, Issue:4
| A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. |
| AID1347105 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347098 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347094 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347092 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347101 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1346986 | P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5
| A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
| AID1347086 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID1347154 | Primary screen GU AMC qHTS for Zika virus inhibitors | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
| Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
| AID1347104 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347091 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347103 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347107 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
| AID1347425 | Rhodamine-PBP qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1) | 2019 | The Journal of biological chemistry, 11-15, Volume: 294, Issue:46
| Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens. |
| AID1346987 | P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5
| A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
| AID1347083 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID1347102 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4
| Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID692032 | Inhibition of PKA in mouse B16-F1 cells assessed as decrease of dopachrome tautomerase mRNA expression at 3 uM after 72 hrs by RT-PCR analysis | 2012 | Journal of natural products, Oct-26, Volume: 75, Issue:10
| Dual inhibition of γ-oryzanol on cellular melanogenesis: inhibition of tyrosinase activity and reduction of melanogenic gene expression by a protein kinase A-dependent mechanism. |
| AID689820 | Inhibition of PKA in mouse B16-F1 cells assessed as decrease of MITF mRNA expression at 3 uM after 72 hrs by RT-PCR analysis relative to control | 2012 | Journal of natural products, Oct-26, Volume: 75, Issue:10
| Dual inhibition of γ-oryzanol on cellular melanogenesis: inhibition of tyrosinase activity and reduction of melanogenic gene expression by a protein kinase A-dependent mechanism. |
| AID689825 | Inhibition of PKA in mouse B16-F1 cells assessed as decrease of dopachrome tautomerase protein expression at 3 uM after 72 hrs by immunoblotting relative to control | 2012 | Journal of natural products, Oct-26, Volume: 75, Issue:10
| Dual inhibition of γ-oryzanol on cellular melanogenesis: inhibition of tyrosinase activity and reduction of melanogenic gene expression by a protein kinase A-dependent mechanism. |
| AID288763 | Inhibition of TPA-induced Epstein-Barr virus early antigen activation assessed as EBV-EA induction in Raji cells at 0.32 nM after 48 hrs relative to TPA | 2007 | Journal of natural products, Jun, Volume: 70, Issue:6
| Cancer chemopreventive effects of cycloartane-type and related triterpenoids in in vitro and in vivo models. |
| AID616386 | Antioxidant activity assessed DPPH scavenging activity at 500 uM | 2011 | Journal of natural products, Sep-23, Volume: 74, Issue:9
| Anti-inflammatory principles from Cordyceps sinensis. |
| AID692029 | Inhibition of tyrosinase in mouse B16-F1 cells using L-DOPA as substrate at 30 uM after 72 hrs | 2012 | Journal of natural products, Oct-26, Volume: 75, Issue:10
| Dual inhibition of γ-oryzanol on cellular melanogenesis: inhibition of tyrosinase activity and reduction of melanogenic gene expression by a protein kinase A-dependent mechanism. |
| AID689821 | Inhibition of PKA in mouse B16-F1 cells assessed as decrease of TRP-1 mRNA expression at 3 uM after 72 hrs by RT-PCR analysis relative to control | 2012 | Journal of natural products, Oct-26, Volume: 75, Issue:10
| Dual inhibition of γ-oryzanol on cellular melanogenesis: inhibition of tyrosinase activity and reduction of melanogenic gene expression by a protein kinase A-dependent mechanism. |
| AID689816 | Inhibition of PKA in mouse B16-F1 cells at 3 uM after 72 hrs by solid phase enzyme-linked immunosorbent assay | 2012 | Journal of natural products, Oct-26, Volume: 75, Issue:10
| Dual inhibition of γ-oryzanol on cellular melanogenesis: inhibition of tyrosinase activity and reduction of melanogenic gene expression by a protein kinase A-dependent mechanism. |
| AID600421 | Antiviral activity against HIV1 Reverse transcriptase activity | 2009 | Bioorganic & medicinal chemistry, Jul-15, Volume: 17, Issue:14
| Novel 3alpha-methoxyserrat-14-en-21beta-ol (PJ-1) and 3beta-methoxyserrat-14-en-21beta-ol (PJ-2)-curcumin, kojic acid, quercetin, and baicalein conjugates as HIV agents. |
| AID692036 | Inhibition of PKA in mouse B16-F1 cells assessed as decrease of CREB mRNA expression at 3 uM after 72 hrs by RT-PCR analysis | 2012 | Journal of natural products, Oct-26, Volume: 75, Issue:10
| Dual inhibition of γ-oryzanol on cellular melanogenesis: inhibition of tyrosinase activity and reduction of melanogenic gene expression by a protein kinase A-dependent mechanism. |
| AID689817 | Inhibition of PKA in mouse B16-F1 cells assessed as decrease of phosphorylated CREB expression at 3 uM after 72 hrs by immunoblotting | 2012 | Journal of natural products, Oct-26, Volume: 75, Issue:10
| Dual inhibition of γ-oryzanol on cellular melanogenesis: inhibition of tyrosinase activity and reduction of melanogenic gene expression by a protein kinase A-dependent mechanism. |
| AID692037 | Inhibition of PKA in mouse B16-F1 cells assessed as decrease of MC1R mRNA expression at 3 uM after 72 hrs by RT-PCR analysis | 2012 | Journal of natural products, Oct-26, Volume: 75, Issue:10
| Dual inhibition of γ-oryzanol on cellular melanogenesis: inhibition of tyrosinase activity and reduction of melanogenic gene expression by a protein kinase A-dependent mechanism. |
| AID689818 | Inhibition of PKA in mouse B16-F1 cells assessed as effect on ERK2 phosphorylation at 3 uM after 72 hrs by immunoblotting | 2012 | Journal of natural products, Oct-26, Volume: 75, Issue:10
| Dual inhibition of γ-oryzanol on cellular melanogenesis: inhibition of tyrosinase activity and reduction of melanogenic gene expression by a protein kinase A-dependent mechanism. |
| AID689822 | Inhibition of PKA in mouse B16-F1 cells assessed as decrease of dopachrome tautomerase mRNA expression at 3 uM after 72 hrs by RT-PCR analysis relative to control | 2012 | Journal of natural products, Oct-26, Volume: 75, Issue:10
| Dual inhibition of γ-oryzanol on cellular melanogenesis: inhibition of tyrosinase activity and reduction of melanogenic gene expression by a protein kinase A-dependent mechanism. |
| AID689819 | Inhibition of PKA in mouse B16-F1 cells assessed as effect on ERK2 mRNA expression at 3 uM after 72 hrs by RT-PCR analysis | 2012 | Journal of natural products, Oct-26, Volume: 75, Issue:10
| Dual inhibition of γ-oryzanol on cellular melanogenesis: inhibition of tyrosinase activity and reduction of melanogenic gene expression by a protein kinase A-dependent mechanism. |
| AID689824 | Inhibition of PKA in mouse B16-F1 cells assessed as decrease of TRP-1 protein expression at 3 uM after 72 hrs by immunoblotting relative to control | 2012 | Journal of natural products, Oct-26, Volume: 75, Issue:10
| Dual inhibition of γ-oryzanol on cellular melanogenesis: inhibition of tyrosinase activity and reduction of melanogenic gene expression by a protein kinase A-dependent mechanism. |
| AID288760 | Inhibition of TPA-induced Epstein-Barr virus early antigen activation assessed as EBV-EA induction in Raji cells at 320 nM after 48 hrs relative to TPA | 2007 | Journal of natural products, Jun, Volume: 70, Issue:6
| Cancer chemopreventive effects of cycloartane-type and related triterpenoids in in vitro and in vivo models. |
| AID616300 | Anti-inflammatory activity in human neutrophils assessed as inhibition of FMLP/CB-induced superoxide anion generation at 10 ug/mL | 2011 | Journal of natural products, Sep-23, Volume: 74, Issue:9
| Anti-inflammatory principles from Cordyceps sinensis. |
| AID377039 | Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay | 2005 | Journal of natural products, Jan, Volume: 68, Issue:1
| Cytotoxic hydroxylated triterpene alcohol ferulates from rice bran. |
| AID692025 | Inhibition of melanin synthesis in mouse B16-F1 cells after 72 hrs by spectrophotometric analysis | 2012 | Journal of natural products, Oct-26, Volume: 75, Issue:10
| Dual inhibition of γ-oryzanol on cellular melanogenesis: inhibition of tyrosinase activity and reduction of melanogenic gene expression by a protein kinase A-dependent mechanism. |
| AID692031 | Inhibition of PKA in mouse B16-F1 cells assessed as decrease of TRP-1 mRNA expression at 3 uM after 72 hrs by RT-PCR analysis | 2012 | Journal of natural products, Oct-26, Volume: 75, Issue:10
| Dual inhibition of γ-oryzanol on cellular melanogenesis: inhibition of tyrosinase activity and reduction of melanogenic gene expression by a protein kinase A-dependent mechanism. |
| AID692024 | Inhibition of melanin synthesis in mouse B16-F1 cells at 30 uM after 72 hrs by spectrophotometric analysis relative to control | 2012 | Journal of natural products, Oct-26, Volume: 75, Issue:10
| Dual inhibition of γ-oryzanol on cellular melanogenesis: inhibition of tyrosinase activity and reduction of melanogenic gene expression by a protein kinase A-dependent mechanism. |
| AID692034 | Inhibition of PKA in mouse B16-F1 cells assessed as decrease of MITF promoter- dependent sex-determining region Y-box 10 mRNA expression at 3 uM after 72 hrs by RT-PCR analysis | 2012 | Journal of natural products, Oct-26, Volume: 75, Issue:10
| Dual inhibition of γ-oryzanol on cellular melanogenesis: inhibition of tyrosinase activity and reduction of melanogenic gene expression by a protein kinase A-dependent mechanism. |
| AID288762 | Inhibition of TPA-induced Epstein-Barr virus early antigen activation assessed as EBV-EA induction in Raji cells at 3.2 nM after 48 hrs relative to TPA | 2007 | Journal of natural products, Jun, Volume: 70, Issue:6
| Cancer chemopreventive effects of cycloartane-type and related triterpenoids in in vitro and in vivo models. |
| AID692033 | Inhibition of PKA in mouse B16-F1 cells assessed as decrease of MITF promoter- dependent paired-box 3 mRNA expression at 3 uM after 72 hrs by RT-PCR analysis | 2012 | Journal of natural products, Oct-26, Volume: 75, Issue:10
| Dual inhibition of γ-oryzanol on cellular melanogenesis: inhibition of tyrosinase activity and reduction of melanogenic gene expression by a protein kinase A-dependent mechanism. |
| AID692021 | Inhibition of melanin synthesis in mouse B16-F1 cells at 30 uM after 30 mins by Fontana-Masson staining | 2012 | Journal of natural products, Oct-26, Volume: 75, Issue:10
| Dual inhibition of γ-oryzanol on cellular melanogenesis: inhibition of tyrosinase activity and reduction of melanogenic gene expression by a protein kinase A-dependent mechanism. |
| AID692030 | Inhibition of PKA in mouse B16-F1 cells assessed as decrease of MITF mRNA expression at 3 uM after 72 hrs by RT-PCR analysis | 2012 | Journal of natural products, Oct-26, Volume: 75, Issue:10
| Dual inhibition of γ-oryzanol on cellular melanogenesis: inhibition of tyrosinase activity and reduction of melanogenic gene expression by a protein kinase A-dependent mechanism. |
| AID288765 | Cell viability of Raji cells at 320 nM | 2007 | Journal of natural products, Jun, Volume: 70, Issue:6
| Cancer chemopreventive effects of cycloartane-type and related triterpenoids in in vitro and in vivo models. |
| AID689823 | Inhibition of PKA in mouse B16-F1 cells assessed as decrease of MITF protein expression at 3 uM after 72 hrs by immunoblotting relative to control | 2012 | Journal of natural products, Oct-26, Volume: 75, Issue:10
| Dual inhibition of γ-oryzanol on cellular melanogenesis: inhibition of tyrosinase activity and reduction of melanogenic gene expression by a protein kinase A-dependent mechanism. |
| AID288761 | Inhibition of TPA-induced Epstein-Barr virus early antigen activation assessed as EBV-EA induction in Raji cells at 32 nM after 48 hrs relative to TPA | 2007 | Journal of natural products, Jun, Volume: 70, Issue:6
| Cancer chemopreventive effects of cycloartane-type and related triterpenoids in in vitro and in vivo models. |
| AID288764 | Inhibition of TPA-induced Epstein-Barr virus early antigen activation in Raji cells after 48 hrs | 2007 | Journal of natural products, Jun, Volume: 70, Issue:6
| Cancer chemopreventive effects of cycloartane-type and related triterpenoids in in vitro and in vivo models. |
| AID692028 | Inhibition of tyrosinase in mouse B16-F1 cells using L-DOPA as substrate at 3 uM after 72 hrs | 2012 | Journal of natural products, Oct-26, Volume: 75, Issue:10
| Dual inhibition of γ-oryzanol on cellular melanogenesis: inhibition of tyrosinase activity and reduction of melanogenic gene expression by a protein kinase A-dependent mechanism. |
| AID692038 | Inhibition of PKA in mouse B16-F1 cells assessed as decrease of intracellular cAMP level at 3 uM after 72 hrs by colorimetric competitive immunoassay | 2012 | Journal of natural products, Oct-26, Volume: 75, Issue:10
| Dual inhibition of γ-oryzanol on cellular melanogenesis: inhibition of tyrosinase activity and reduction of melanogenic gene expression by a protein kinase A-dependent mechanism. |
| AID288766 | Scavenging activity against NO generation in human Chang liver cells assessed as inhibition of NOR1-activation at 350 nM relative to NOR1 | 2007 | Journal of natural products, Jun, Volume: 70, Issue:6
| Cancer chemopreventive effects of cycloartane-type and related triterpenoids in in vitro and in vivo models. |
| AID692022 | Inhibition of mushroom tyrosinase after 20 mins | 2012 | Journal of natural products, Oct-26, Volume: 75, Issue:10
| Dual inhibition of γ-oryzanol on cellular melanogenesis: inhibition of tyrosinase activity and reduction of melanogenic gene expression by a protein kinase A-dependent mechanism. |
| AID692023 | Inhibition of melanin synthesis in mouse B16-F1 cells at 3 uM after 72 hrs by spectrophotometric analysis relative to control | 2012 | Journal of natural products, Oct-26, Volume: 75, Issue:10
| Dual inhibition of γ-oryzanol on cellular melanogenesis: inhibition of tyrosinase activity and reduction of melanogenic gene expression by a protein kinase A-dependent mechanism. |
| AID692027 | Cytotoxicity against mouse B16-F1 cells at 5 mM | 2012 | Journal of natural products, Oct-26, Volume: 75, Issue:10
| Dual inhibition of γ-oryzanol on cellular melanogenesis: inhibition of tyrosinase activity and reduction of melanogenic gene expression by a protein kinase A-dependent mechanism. |
| AID692035 | Inhibition of PKA in mouse B16-F1 cells assessed as decrease of MITF promoter- dependent lymphoid enhancer factor mRNA expression at 3 uM after 72 hrs by RT-PCR analysis | 2012 | Journal of natural products, Oct-26, Volume: 75, Issue:10
| Dual inhibition of γ-oryzanol on cellular melanogenesis: inhibition of tyrosinase activity and reduction of melanogenic gene expression by a protein kinase A-dependent mechanism. |
| AID616384 | Anti-inflammatory activity in human neutrophils assessed as inhibition of FMLP/CB-induced elastase release at 10 ug/mL | 2011 | Journal of natural products, Sep-23, Volume: 74, Issue:9
| Anti-inflammatory principles from Cordyceps sinensis. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |